Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung-Hsin Chang

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|November 7, 2024
Platelet-derived mitochondria regulate lipid metabolism in nonalcoholic steatohepatitis through extracellular vesiclesTsai-Ling Liao, Der-Yuan Chen, Shie-Liang Hsieh, et al.
World Journal of Oncology|November 10, 2025
Utility of Alpha-Fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II Kinetics in Predicting Radiologic Response and Survival in Unresectable Hepatocellular Carcinoma Undergoing ImmunotherapyShou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, et al.
Plos One|March 7, 2017
Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese menChung-Hsin Chang, Cheng-Pin Wu, Jung-Der Wang, et al.
Cancers|September 27, 2025
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on ImmunotherapyShou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, et al.
Digestive Diseases (Basel, Switzerland)|February 23, 2025
HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative PatientsYi-Jie Huang, Shou-Wu Lee, Chun-Fang Tung, et al.
Therapeutic Advances in Gastroenterology|September 29, 2025
Efficacy and safety of Risankizumab for moderate-to-severe Crohn's disease: first Asian real-world data (STAR trial)Chen-Shuan Chung, Chung-Hsin Chang, Chia-Jung Kuo, et al.
Archives of Gerontology and Geriatrics|December 17, 2009
Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly menChung-Hsin Chang, Yi-Ming Chen, Ya-Wen Chuang, et al.
Scientific Reports|January 2, 2025
Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosisYi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 13, 2025
Predictive factors and clinical outcomes in decompensated non-cirrhotic chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarateYi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Journal of Clinical Medicine|December 23, 2023
Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative PatientsYi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|November 7, 2024
Platelet-derived mitochondria regulate lipid metabolism in nonalcoholic steatohepatitis through extracellular vesiclesTsai-Ling Liao, Der-Yuan Chen, Shie-Liang Hsieh, et al.
World Journal of Oncology|November 10, 2025
Utility of Alpha-Fetoprotein and Protein Induced by Vitamin K Absence or Antagonist-II Kinetics in Predicting Radiologic Response and Survival in Unresectable Hepatocellular Carcinoma Undergoing ImmunotherapyShou-Wu Lee, Hsin-Ju Tsai, Chia-Chang Chen, et al.
Plos One|March 7, 2017
Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese menChung-Hsin Chang, Cheng-Pin Wu, Jung-Der Wang, et al.
Cancers|September 27, 2025
CRAFITY and AFP/PIVKA-II Kinetics Predict Prognosis in Hepatocellular Carcinoma on ImmunotherapyShou-Wu Lee, Yi-Jie Huang, Ying-Cheng Lin, et al.
Digestive Diseases (Basel, Switzerland)|February 23, 2025
HBV Relapse after Discontiniuation of Tenofovir Alafenamide or Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative PatientsYi-Jie Huang, Shou-Wu Lee, Chun-Fang Tung, et al.
Therapeutic Advances in Gastroenterology|September 29, 2025
Efficacy and safety of Risankizumab for moderate-to-severe Crohn's disease: first Asian real-world data (STAR trial)Chen-Shuan Chung, Chung-Hsin Chang, Chia-Jung Kuo, et al.
Archives of Gerontology and Geriatrics|December 17, 2009
Relationship between hyperuricemia (HUC) and metabolic syndrome (MS) in institutionalized elderly menChung-Hsin Chang, Yi-Ming Chen, Ya-Wen Chuang, et al.
Scientific Reports|January 2, 2025
Determinants of outcomes in patients with hepatitis B virus-decompensated cirrhosisYi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 13, 2025
Predictive factors and clinical outcomes in decompensated non-cirrhotic chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarateYi-Jie Huang, Jun-Sing Wang, Cheng-Hsu Chen, et al.
Journal of Clinical Medicine|December 23, 2023
Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative PatientsYi-Jie Huang, Tsai-Chung Li, Cheng-Hsu Chen, et al.
Pageof 5